Aussie Government Panel Accuses TGA Of Laxity In Approvals
This article was originally published in PharmAsia News
Executive Summary
One arm of the Australian government is accusing the Therapeutics Goods Administration of slipshod review work that allows questionable drugs and medical devices on the market. The Prostheses and Devices Committee, a government-appointed panel, reported the TGA has cleared some products despite a lack of support by the clinical studies submitted for the approval process. The committee said some of its members, who include medical professionals, believe TGA's review procedures are inadequate. The committee is considering how to coordinate the federal process of approving products with the programs for funding them. (Click here for more